International Clinical Trial: IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07361874) titled 'IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion' on Jan. 20.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Texas Southwestern Medical Center

Condition: Mild Autonomous Cortisol Secretion (MACS) Autonomous Cortisol Secretion (ACS) Subclinical Cushing's Mild Autonomous Cortisol Excess

Intervention: Procedure: Intervention 1: Adrenalectomy

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: F...